BackAvalyn Pharma Common Stock Overview

Avalyn Pharma Common Stock Total Liabilities

Track Avalyn Pharma Common Stock's total liabilities ($27M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$27.10M

Peer trimmed avg / median

Loading

Avalyn Pharma Common Stock Total Liabilities History

Loading

Avalyn Pharma Common Stock vs. peers: Total Liabilities Comparison

Loading

Avalyn Pharma Common Stock Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Avalyn Pharma Common Stock (AVLN) FAQ

Avalyn Pharma Common Stock (AVLN) currently reports a total liabilities of $27M as of June 2026. Use the charts on this page to explore Avalyn Pharma Common Stock's total liabilities history and peer comparisons.

Avalyn Pharma Common Stock reported $27M in total liabilities as of June 2026. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $27M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Avalyn Pharma Common Stock, and consider following AVLN for alerts when major investors trade the stock.

Avalyn Pharma Common Stock is classified in the Healthcare sector. On total liabilities, it currently shows $27M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing AVLN with unrelated industries.